Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non-inferiority, randomized controlled trial.

Name: Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non-inferiority, randomized controlled trial.
Author: Wen, Bingbing

Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non-inferiority, randomized controlled trial. — المؤلف: Wen, Bingbing — Hematological oncology 20221007

المؤلف: Wen, Bingbing
النشر: Hematological oncology 20221007
الوصف: 777-786 p.
الموضوعات: Benzoates؛ Hematopoietic Stem Cell Transplantation؛ Humans؛ Hydrazines؛ Prospective Studies؛ Pyrazoles؛ Recombinant Proteins؛ Thrombopoietin